N6-Benzyladenosine-5'-O-diphosphate (sodium salt)
(Synonyms: N6-benzyl ADP) 目录号 : GC90800一种ADP衍生物和N6-苄基腺嘌呤的活性代谢产物。
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
N6-Benzyladenosine-5'-O-diphosphate is a derivative of ADP and an active metabolite of the cytokinin N6-benzyladenine .1,2,3 It inhibits the ATPase activities of mortalin, heat shock protein 70 (Hsp70), and heat shock cognate 71 kDa protein (Hsc70; apparent Kis = 86.51, 294.5, and 1,612 µM, respectively, for the human enzymes).2 N6-Benzyladenosine-5'-O-diphosphate inhibits the proliferation of CEM, HL-60, and K562 leukemia, RPMI-8226 multiple myeloma, and MCF-7 breast cancer cells (IC50s = 2, 1.3, 4, 4.5, and 8 µM, respectively).3 It has also been used in the synthesis of radiolabeled and unlabeled forms of N6-benzyladenosine 5'-(γ-thio)-triphosphate (N6-benzyl-ATPγS), which have been used to determine kinase activity.4,5
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.7144 mL | 8.5719 mL | 17.1438 mL |
5 mM | 0.3429 mL | 1.7144 mL | 3.4288 mL |
10 mM | 0.1714 mL | 0.8572 mL | 1.7144 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。